An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis

Clinical trial NCT00463151 · COMPLETED

Trial details

NCT number: NCT00463151
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2007-06-01
Primary completion: 2008-08-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.